Advanced Pharmacology Fundamentals | Questions &
Answers | 100% Correct | Grade A - Chamberlain
Which of the following best describes asthma?
A chronic inflammatory airway disorder with reversible airflow obstruction
3 multiple choice options
Which of the following is most likely to trigger an asthma attack?
Exercise or respiratory infection
3 multiple choice options
What is the underlying pathological process in asthma?
Inflammation leading to airway hyperresponsiveness
3 multiple choice options
Which of the following symptoms is most characteristic of asthma?
Chest tightness and wheezing, especially at night
3 multiple choice options
What is the mechanism of action of ipratropium in the treatment of asthma or COPD?
Inhibits muscarinic receptors to prevent bronchoconstriction
3 multiple choice options
,Ipratropium is primarily classified as which of the following?
Short-acting muscarinic antagonist (SAMA)
3 multiple choice options
Which of the following is a common side effect associated with inhaled ipratropium use?
Dry mouth
3 multiple choice options
In which patient population is ipratropium most commonly used as first-line therapy?
Patients with COPD
3 multiple choice options
Ipratropium may be used as adjunctive therapy in asthma primarily to:
Provide additional bronchodilation when beta-agonists alone are insufficient
3 multiple choice options
Omalizumab is classified as which type of medication?
Monoclonal antibody
3 multiple choice options
What is the primary mechanism of action of omalizumab in asthma treatment?
,Binds to IgE to prevent mast cell activation
3 multiple choice options
Omalizumab is most appropriate for which type of asthma patient?
A patient with moderate to severe allergic asthma not controlled by ICS
3 multiple choice options
What is a serious adverse effect associated with omalizumab that requires post-injection
monitoring that requires it to have a black box warning?
Anaphylaxis
3 multiple choice options
How is omalizumab typically administered?
Subcutaneously or intravenously
3 multiple choice options
What is the primary mechanism of action of bronchodilators in the treatment of asthma and
COPD?
Relaxing bronchial smooth muscle to relieve airway obstruction
3 multiple choice options
Which of the following is considered a short-acting beta-2 agonist (SABA)?
Albuterol
, 3 multiple choice options
What is the primary therapeutic role of LABAs (long-acting beta-2 agonists)?
Long-term control of asthma symptoms
3 multiple choice options
Which of the following is a common adverse effect associated with beta-2 agonist
bronchodilators?
Tremors
3 multiple choice options
What is the therapeutic benefit of bronchodilators in patients with COPD or asthma?
Improving airflow and reducing shortness of breath
3 multiple choice options
What is the primary mechanism of action of theophylline in asthma management?
Inhibiting phosphodiesterase to increase cyclic AMP and cause bronchodilation
3 multiple choice options
Which of the following is a major concern when using theophylline for asthma treatment?
Potential toxicity due to narrow therapeutic index
3 multiple choice options